Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,958 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
SRX3177, a CDK4/6-PI3K-BET inhibitor, in combination with an RdRp inhibitor, Molnupiravir, or an entry inhibitor MU-UNMC-2, has potent antiviral activity against the Omicron variant of SARS-CoV-2.
Pandey K, Acharya A, Pal D, Jain P, Singh K, Durden DL, Kutateladze TG, Deshpande AJ, Byrareddy SN. Pandey K, et al. Among authors: singh k. Antiviral Res. 2024 Jul;227:105904. doi: 10.1016/j.antiviral.2024.105904. Epub 2024 May 8. Antiviral Res. 2024. PMID: 38729306
Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs.
Neogi U, Hill KJ, Ambikan AT, Heng X, Quinn TP, Byrareddy SN, Sönnerborg A, Sarafianos SG, Singh K. Neogi U, et al. Among authors: singh k. Pathogens. 2020 Apr 26;9(5):320. doi: 10.3390/pathogens9050320. Pathogens. 2020. PMID: 32357471 Free PMC article.
Infectivity of SARS-CoV-2: there Is Something More than D614G?
Kannan SR, Spratt AN, Quinn TP, Heng X, Lorson CL, Sönnerborg A, Byrareddy SN, Singh K. Kannan SR, et al. Among authors: singh k. J Neuroimmune Pharmacol. 2020 Dec;15(4):574-577. doi: 10.1007/s11481-020-09954-3. Epub 2020 Sep 15. J Neuroimmune Pharmacol. 2020. PMID: 32930936 Free PMC article. No abstract available.
Factors Associated with Emerging and Re-emerging of SARS-CoV-2 Variants.
Spratt AN, Kannan SR, Woods LT, Weisman GA, Quinn TP, Lorson CL, Sönnerborg A, Byrareddy SN, Singh K. Spratt AN, et al. Among authors: singh k. bioRxiv [Preprint]. 2021 Mar 24:2021.03.24.436850. doi: 10.1101/2021.03.24.436850. bioRxiv. 2021. PMID: 33791700 Free PMC article. Preprint.
Therapeutic implications of SARS-CoV-2 dysregulation of the gut-brain-lung axis.
Johnson SD, Olwenyi OA, Bhyravbhatla N, Thurman M, Pandey K, Klug EA, Johnston M, Dyavar SR, Acharya A, Podany AT, Fletcher CV, Mohan M, Singh K, Byrareddy SN. Johnson SD, et al. Among authors: singh k. World J Gastroenterol. 2021 Aug 7;27(29):4763-4783. doi: 10.3748/wjg.v27.i29.4763. World J Gastroenterol. 2021. PMID: 34447225 Free PMC article. Review.
9,958 results